Publication | Open Access
Clinical manifestations of the anti-IgLON5 disease
402
Citations
9
References
2017
Year
Patients with IgLON5 antibodies develop a characteristic sleep disorder preceded or accompanied by bulbar symptoms, gait abnormalities, oculomotor problems, and, less frequently, cognitive decline. IgG4 subclass antibodies predominate over IgG1; we confirm a strong association with the HLA-DRB1*10:01 allele.
| Year | Citations | |
|---|---|---|
1988 | 6.3K | |
2014 | 531 | |
2016 | 232 | |
2016 | 151 | |
2015 | 69 | |
2013 | 62 | |
2013 | 61 | |
2015 | 56 | |
2010 | 51 |
Page 1
Page 1